Human Metabolome Technologies, Inc. (6090.T)

JPY 604.0

(0.0%)

Total Debt Summary of Human Metabolome Technologies, Inc.

  • Human Metabolome Technologies, Inc.'s latest annual total debt in 2023 was 226.3 Million JPY , down -0.1% from previous year.
  • Human Metabolome Technologies, Inc.'s latest quarterly total debt in 2023 FY was 226.3 Million JPY , down -0.1% from previous quarter.
  • Human Metabolome Technologies, Inc. reported annual total debt of 226.52 Million JPY in 2022, down -2.86% from previous year.
  • Human Metabolome Technologies, Inc. reported annual total debt of 233.19 Million JPY in 2021, up 52.71% from previous year.
  • Human Metabolome Technologies, Inc. reported quarterly total debt of 226.3 Million JPY for 2023 Q4, down -1.22% from previous quarter.
  • Human Metabolome Technologies, Inc. reported quarterly total debt of 229.1 Million JPY for 2023 Q3, up 4.45% from previous quarter.

Annual Total Debt Chart of Human Metabolome Technologies, Inc. (2023 - 2019)

Historical Annual Total Debt of Human Metabolome Technologies, Inc. (2023 - 2019)

Year Total Debt Total Debt Growth
2023 226.3 Million JPY -0.1%
2022 226.52 Million JPY -2.86%
2021 233.19 Million JPY 52.71%
2020 152.7 Million JPY 674.08%
2019 19.72 Million JPY 0.0%

Peer Total Debt Comparison of Human Metabolome Technologies, Inc.

Name Total Debt Total Debt Difference
Shin Nippon Biomedical Laboratories, Ltd. 26.33 Billion JPY 99.141%
DNA Chip Research Inc. - JPY -Infinity%
Cosmo Bio Company,Limited 20 Million JPY -1031.515%
H.U. Group Holdings, Inc. 81.94 Billion JPY 99.724%
FALCO HOLDINGS Co., Ltd. 817 Million JPY 72.301%
BML, Inc. 5.26 Billion JPY 95.702%
Precision System Science Co., Ltd. 1.36 Billion JPY 83.441%